Category: Pharmaceuticals
Asia Pharmaceuticals
-
ePharmacy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... billion in 2025 to US$ 640 billion by 2032, registering a remarkable CAGR of 16.40% during the forecast period. This explosive growth reflects the increasing consumer preference for online medication services over traditional pharmacy models. ... Read More
-
Pharmaceutical Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More
-
Medical Plant & Herb Processing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ... Read More
-
Viral Vector Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... human cells, have demonstrated notable efficacy against threats like Ebola and COVID-19. According to a recent study by Fairfield Market Research, the viral vector vaccines market is anticipated to grow from US$ 872.4 million in ... Read More
-
Medicine Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More
-
Biological Product Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk, Forecasts, & Tariff Analysis (Updated with China tariffs at 30%)
... report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 ... Read More
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... biopsies and surgeries, ensuring accurate diagnosis and targeted treatment of breast cancer. According to market analysis, the global breast tissue markers market is expected to grow from US$ 3.3 billion in 2025 to US$ 6.1 ... Read More
-
Breast Recurrence Score Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... rate (CAGR) of 10.00% during the forecast period. Rising global breast cancer incidence, technological progress in genomic profiling, and the increasing preference for non-invasive diagnostic methods are driving the market forward. Market Insights Breast recurrence ... Read More
-
Global & Vietnam Cancer Therapeutics Market to 2031
... access to cancer care services. The Vietnamese Ministry of Health has teamed up with global pharma companies to increase the availability of oncology drugs within public healthcare facilities. These efforts have helped bring innovative cancer ... Read More
-
Global & South Korea Cancer Therapeutics Market to 2031
... approximately 274,488 new cancer cases that year. Thyroid cancer topped the list as the most frequently diagnosed, followed by lung, colorectal, breast, and stomach cancers. This growing cancer burden is fueling a corresponding surge in ... Read More
-
Global & Turkey Cancer Therapeutics Market to 2031
... including immunotherapy and targeted therapies. In response, the Turkish government has launched several initiatives to enhance the development and accessibility of such treatments. One key effort is the Ministry of Health's National Cancer Control Program, ... Read More
-
Global & Bangladesh Cancer Therapeutics Market to 2031
... producing generic cancer medications, which helps make treatments more affordable and accessible to a larger segment of patients. However, the market faces challenges including the absence of widespread cancer screening programs, limited availability of advanced ... Read More
-
Global & Malaysia Cancer Therapeutics Market to 2031
... improve patient survival rates, the Ministry of Health established the National Cancer Control Blueprint. Data from the National Cancer Registry (NCR) indicates that approximately 50,000 new cancer cases are diagnosed annually in Malaysia, with breast, ... Read More
-
Global & Thailand Cancer Therapeutics Market to 2031
... inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become more accessible in Thailand, offering promising options for patients with melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and other cancers. These therapies enhance the immune ... Read More
-
Global & Japan Cancer Therapeutics Market to 2031
... least 500,000 individuals in the country are aged 65 or older. Projections from Japan’s National Institute of Population and Social Security Research estimate that by 2050, 37.7% of the population will fall into this age ... Read More
-
Global & Indonesia Cancer Therapeutics Market to 2031
... new cancer cases and nearly 300,000 cancer-related deaths. Factors such as a large population base, tobacco use, poor dietary habits, and environmental pollution are key contributors to the increasing incidence of cancer. In response, the ... Read More
-
Global & Russia Cancer Therapeutics Market to 2031
... saw over 600,000 new cancer cases in 2023, alongside approximately 300,000 cancer-related deaths. The most common cancers include lung, breast, colorectal, and prostate cancers, with lung cancer posing a major challenge due to high smoking ... Read More
-
Global & Singapore Cancer Therapeutics Market to 2031
... one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct ... Read More
-
Global & China Cancer Therapeutics Market to 2031
... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More
-
Global & India Cancer Therapeutics Market to 2031
... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
India Biosimilars Market Overview, 2030
... cannot replicate their reference biologics precisely due to inherent biological complexity and variability. In India, the adoption of biosimilars has gained momentum, with significant contributions to healthcare accessibility and affordability, backed by robust regulatory frameworks ... Read More
-
China Biosimilars Market Overview, 2030
... corresponding regulations and guidelines to encourage the development of biosimilars. China, as a populous nation with a substantial demand for biologic therapies, has made substantial investments in the research and development (R&D) of a number ... Read More
Research Assistance
